Summary
The global Alfacalcidol Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Alfacalcidol is used as a supplement to treat a medical condition associated with the deficiency of Vitamin D such as osteoporosis and hypocalcemia. It is also used to treat osteoporosis and hypocalcemia, Renal Osteodystrophy, Osteomalacia, and Rickets. Moreover, alfacalcidol is an effective antioxidant, this particular supplement is a powerful tonic. It also helps to provide relief from many other medical conditions as helps to strengthen the immune system. Furthermore, this particular supplement also helps to improve a person's health by helping to maintain a healthy heart.
The growing prevalence of deficiency of Vitamin D associated with medical conditions such as osteoporosis and hypocalcemia (weakening of bones) is primarily fueling the market growth of alfacalcidol. According to the International Osteoporosis Foundation, around the world, at least one in three women and one in five men over the age of 50 suffer a fracture caused by weak bones. Moreover, the growing use of alfacalcidol for treating calcium metabolism disturbances caused due to kidneys and the parathyroid gland is again augmenting the market growth. Thus, the rising prevalence of kidneys and thyroids around the globe is also fueling the market growth of the alfacalcidol.
Additionally, the growing geriatric population which is highly susceptible to weaken bone is again propelling the market growth of the alfacalcidol over the forecast timeframe. According to the United Nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over.
North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of osteoporosis in the region. According to the National Osteoporosis Foundation, osteoporosis is a disease of the bone that makes a person’s bones weak and more likely to break. Around 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at high risk. Moreover, 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone
Key Developments:
In September 2020, LEO Pharma announced the sale of a portfolio of four non-core products to Germany’s Cheplapharm Arzneimittel for 300 million euros ($357 million). The divested portfolio comprises four products within bone disorders/nephrology, dermatology, and gynecology: One-Alpha (alfacalcidol), Locoid (hydrocortisone butyrate), Pimafucin (natamycin), and Zineryt (erythromycin).
The Alfacalcidol Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Alfacalcidol Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Abcam
- YaoPharma
- Kunming Baker Norton Pharmaceutical
- Teva
- Leo Pharma
- Tocris Bioscience
- LGM Pharma
- ...
By the Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Alfacalcidol Market Report:
- To assess the size of the market by value and volume
- Analyze the Alfacalcidol Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Alfacalcidol Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Alfacalcidol Market
The Alfacalcidol Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Alfacalcidol Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Request Discount 
Inquire Before Buy
